4//SEC Filing
Friedman Mordechai 4
Accession 0001144204-11-041836
CIK 0001137883other
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 6:21 AM ET
Size
8.0 KB
Accession
0001144204-11-041836
Insider Transaction Report
Form 4
Friedman Mordechai
Director
Transactions
- Award
Stock Option (right to buy)
2011-06-27+150,000→ 150,000 totalExercise: $0.15From: 2011-07-27Exp: 2021-06-27→ Common Stock (150,000 underlying) - Award
Stock Option (right to buy)
2011-06-27+16,667→ 16,667 totalExercise: $0.15From: 2011-07-27Exp: 2021-06-27→ Common Stock (16,667 underlying)
Footnotes (2)
- [F1]Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on July 27, 2011 until fully vested and exercisable on the first anniversary of the date of grant, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.
- [F2]Annual option automatically awarded on June 27, 2011 pursuant to the Brainstorm Cell Therapeutics Inc. Director Compensation Plan. Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on July 27, 2011 until fully vested and exercisable on the first anniversary of the date of grant, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001517390
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 6:21 AM ET
- Size
- 8.0 KB